Asia Pacific Myopia Treatment Market Forecast to 2030

Asia Pacific Myopia Treatment Market Forecast to 2030 – Regional Analysis – by Type (High Myopia, Degenerative Myopia, and Progressive Myopia), Treatment [Low-Dose Atropine Eye Drops, Contact Lenses, Ortho-K, and Refractive Surgery (LASIK and PRK)], Age Group (Adult Myopia and Childhood Myopia), and End User (Hospitals and Clinics, Specialty Clinics, and Refractive Surgery Centers)

Send Enquiry

$2,485$3,885

Description

The Asia Pacific myopia treatment market was valued at US$ 3,097.16 million in 2022 and is expected to reach US$ 6,348.64 million by 2030; it is estimated to register a CAGR of 9.4% from 2022 to 2030.

Rising Availability of Advanced Technologies for Treating the Targeted Myopia Boosts Asia Pacific Myopia Treatment Market

The rising availability of advanced technologies for treating targeted myopia is a significant opportunity for the myopia treatment market. Advances in technologies such as laser-assisted in-situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and implantable collamer lenses (ICL) have made it possible to correct myopia more effectively and with fewer complications. Various ground-breaking data were also presented during the congress; over 30 abstracts backed by Johnson & Johnson Vision have been approved for presentation. Surgeons can apply the innovative SILK (i.e., Smooth Incision Lenticule Keratomileusis) treatment to treat myopic patients who have astigmatism or do not utilize the ELITATM Platform. The ELITATM Platform offers surgeons an exceptionally smooth and uncomplicated lenticular removal procedure with next-day outcomes and recovery owing to its fast laser delivery technology and ultra-precise laser pulse. These advanced technologies have traditionally been expensive and inaccessible to many patients. Still, as they become more widely available, they present an opportunity for the myopia treatment market to expand its reach and provide better treatment options to a larger patient population. In addition to these advanced technologies, other emerging treatments such as orthokeratology (ortho-k) and atropine eye drops are gaining popularity as effective methods for managing myopia. The popular orthokeratology contact lens is the latest CooperVision myopia control product to gain the CE Mark, joining EyeDream and Paragon CRT ortho-k designs, MiSight day soft contact lenses, and SightGlass Vision Diffusion Optics Technology spectacle lenses. These non-invasive treatments can be more affordable than surgical options, making them accessible to a wider range of patients. Overall, the rising availability of advanced technologies for treating targeted myopia presents a significant opportunity for the myopia treatment market. By providing patients with more effective and accessible treatment options, the market can help improve vision health outcomes and address a significant unmet need in the global healthcare landscape.

Asia Pacific Myopia Treatment Market Overview

Asia Pacific myopia treatment market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. This region accounted for over 30.14% of the Asia Pacific myopia treatment market in 2022 owing to the increasing aging population, rising number of research studies, growing government support, and increasing eye-related disorders in the region.

In Asia Pacific, China held the largest market share for Asia Pacific myopia treatment market in 2022. The market growth is primarily attributed to the aging population, the increasing prevalence of myopia, and the rising emphasis on preventive care. For instance, according to a study published by the Population Reference Bureau in 2020, the old-age population of China is expected to reach ~366 million by 2050. Moreover, according to the same estimates, around 26% of China’s population will be over 65 by 2050, up from 12% in 2020. Such an extensively increasing geriatric population is anticipated to offer lucrative opportunities for the increased demand for products in the country. The country is also witnessing considerable growth in the prevalence of myopia, particularly in children, which is likely to increase the adoption of treatments in China. For instance, preschoolers and primary and secondary school students in China had a 50.2% prevalence of myopia in 2019, according to the British Journal of Ophthalmology. Additionally, according to the same source, 54.71% of children and adolescents between the ages of 6 and 16 had myopia overall in 2021. Thus, the increasing geriatric population and the increasing prevalence of myopia are driving the market growth.

Asia Pacific Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Myopia Treatment Market Segmentation

The Asia Pacific myopia treatment market is categorized into type, treatment, age group, end user, and country.

Based on type, the Asia Pacific myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest Asia Pacific myopia treatment market share in 2022.

In terms of treatment, the Asia Pacific myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest Asia Pacific myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the Asia Pacific myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger Asia Pacific myopia treatment market share in 2022.

Based on end user, the Asia Pacific myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest Asia Pacific myopia treatment market share in 2022.

Based on country, the Asia Pacific myopia treatment market is categorized into Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific myopia treatment market share in 2022.

Bausch Health Companies Inc, Alcon AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, Nidek Co Ltd, Haag-Streit AG, and Carl Zeiss AG are some of the leading companies operating in the Asia Pacific myopia treatment market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

, ,

Year of Publication:

At 9.4% CAGR, Asia Pacific Myopia Treatment Market is Speculated to be Worth US$ 6,348.64 Million by 2030, says the Research Team

According to the Research Team’ research, the Asia Pacific myopia treatment market was valued at US$ 3,097.16 million in 2022 and is expected to reach US$ 6,348.64 million by 2030, registering a CAGR of 9.4% from 2022 to 2030. Increased awareness of myopia treatment and rising availability of advanced technologies for treating the targeted myopia are among the critical factors attributed to drive the Asia Pacific myopia treatment market growth.

The heightened awareness of myopia treatment options drives the substantial growth of the myopia treatment market. A recent market analysis revealed that the increasing awareness of myopia management strategies, particularly among parents and eyecare professionals, has led to a significant upsurge in implementing myopia control measures. The leader in global eye care is teaming up with three of the best optometry schools in the country to provide extended myopia therapy to a pilot group starting in 2024. As awareness campaigns, educational initiatives, and extensive research studies continue to shed light on the potential consequences of unmanaged myopia, there has been a notable shift toward proactive myopia management approaches. This trend has furthered the adoption of myopia treatment technologies, such as orthokeratology and pharmaceutical interventions, resulting in a remarkable increase in the market size, which has grown by over 25% in the last two years. The collective efforts to raise awareness about myopia as a public health concern and to promote the viability of myopia management solutions are propelling market growth and fostering a culture of proactive vision care. This momentum is likely to continue driving advancements in myopia treatment, emphasizing the pivotal role of awareness in shaping the landscape of myopia management and treatment strategies.

On the contrary, lack of skilled professionals hampers the growth of Asia Pacific myopia treatment market.

Based on type, the Asia Pacific myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held 62.4% market share in 2022, amassing US$ 1,931.24 million. It is projected to garner US$ 4,088.74 million by 2030 to register 9.8% CAGR during 2022-2030.

In terms of treatment, the Asia Pacific myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held 38.2% share of Asia Pacific myopia treatment market in 2022, amassing US$ 1,182.67 million. It is anticipated to garner US$ 2,498.49 million by 2030 to expand at 9.8% CAGR during 2022-2030. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the Asia Pacific myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held 65.3% share of Asia Pacific myopia treatment market in 2022, amassing US$ 2,023.61 million. It is projected to garner US$ 4,232.63 million by 2030 to expand at 9.7% CAGR from 2022 to 2030.

Based on end user, the Asia Pacific myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held 65.5% share of Asia Pacific myopia treatment market in 2022, amassing US$ 2,027.16 million. It is predicted to garner US$ 4,276.26 million by 2030 to expand at 9.8% CAGR between 2022 and 2030.

Based on country, the Asia Pacific myopia treatment market is categorized into Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 38.2% share of Asia Pacific myopia treatment market in 2022. It was assessed at US$ 1,181.56 million in 2022 and is likely to hit US$ 2,659.44 million by 2030, registering a CAGR of 10.7% during 2022-2030.

Key players operating in the Asia Pacific myopia treatment market are Bausch Health Companies Inc, Alcon AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, Nidek Co Ltd, Haag-Streit AG, and Carl Zeiss AG, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific myopia treatment market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific myopia treatment market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific myopia treatment market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Myopia Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Market Share Analysis, By Companies
5. Asia Pacific Myopia Treatment Market – Key Market Dynamics
5.1 Asia Pacific Myopia Treatment Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Myopia
5.2.2 Increased Awareness of Myopia Treatment
5.3 Market Restraints
5.3.1 Lack of Skilled Professionals
5.4 Market Opportunities
5.4.1 Rising Availability of Advanced Technologies for Treating The Targeted Myopia
5.5 Future Trends
5.5.1 Application of Artificial Intelligence in Myopia Treatment
5.6 Impact of Drivers and Restraints:
6. Myopia Treatment Market – Asia Pacific Market Analysis
7. Asia Pacific Myopia Treatment Market Analysis – by Type
7.1 High Myopia
7.1.1 Overview
7.1.2 High Myopia: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Degenerative Myopia
7.2.1 Overview
7.2.2 Degenerative Myopia: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Progressive Myopia
7.3.1 Overview
7.3.2 Progressive Myopia: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Myopia Treatment Market Analysis – by Treatment
8.1 Low-Dose Atropine Eye Drops
8.1.1 Overview
8.1.2 Low-Dose Atropine Eye Drops: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Refractive Surgery
8.2.1 Overview
8.2.2 Refractive Surgery: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2.3 LASIK
8.2.4 PRK
8.3 Contact Lenses
8.3.1 Overview
8.3.2 Contact Lenses: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Ortho-K
8.4.1 Overview
8.4.2 Ortho-K: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Myopia Treatment Market Analysis – by Age Group
9.1 Adult Myopia
9.1.1 Overview
9.1.2 Adult Myopia: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Childhood Myopia
9.2.1 Overview
9.2.2 Childhood Myopia: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Myopia Treatment Market Analysis – by End User
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Specialty Clinics
10.2.1 Overview
10.2.2 Specialty Clinics: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Refractive Surgery Centers
10.3.1 Overview
10.3.2 Refractive Surgery Centers: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11. Asia Pacific Myopia Treatment Market – Country Analysis
11.1 Asia Pacific
11.1.1 Asia Pacific: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.1.1.1 Asia Pacific: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.1.1.2 China
11.1.1.3 China: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 China: Myopia Treatment Market Breakdown, by Type
11.1.1.3.2 China: Myopia Treatment Market Breakdown, by Treatment
11.1.1.3.3 China: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.3.4 China: Myopia Treatment Market Breakdown, by Age Group
11.1.1.3.5 China: Myopia Treatment Market Breakdown, by End User
11.1.1.4 Japan
11.1.1.5 Japan: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Japan: Myopia Treatment Market Breakdown, by Type
11.1.1.5.2 Japan: Myopia Treatment Market Breakdown, by Treatment
11.1.1.5.3 Japan: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.5.4 Japan: Myopia Treatment Market Breakdown, by Age Group
11.1.1.5.5 Japan: Myopia Treatment Market Breakdown, by End User
11.1.1.6 India
11.1.1.7 India: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.7.1 India: Myopia Treatment Market Breakdown, by Type
11.1.1.7.2 India: Myopia Treatment Market Breakdown, by Treatment
11.1.1.7.3 India: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.7.4 India: Myopia Treatment Market Breakdown, by Age Group
11.1.1.7.5 India: Myopia Treatment Market Breakdown, by End User
11.1.1.8 Australia
11.1.1.9 Australia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.9.1 Australia: Myopia Treatment Market Breakdown, by Type
11.1.1.9.2 Australia: Myopia Treatment Market Breakdown, by Treatment
11.1.1.9.3 Australia: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.9.4 Australia: Myopia Treatment Market Breakdown, by Age Group
11.1.1.9.5 Australia: Myopia Treatment Market Breakdown, by End User
11.1.1.10 South Korea
11.1.1.11 South Korea: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.11.1 South Korea: Myopia Treatment Market Breakdown, by Type
11.1.1.11.2 South Korea: Myopia Treatment Market Breakdown, by Treatment
11.1.1.11.3 South Korea: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.11.4 South Korea: Myopia Treatment Market Breakdown, by Age Group
11.1.1.11.5 South Korea: Myopia Treatment Market Breakdown, by End User
11.1.1.12 Rest of Asia Pacific
11.1.1.13 Rest of Asia Pacific: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.13.1 Rest of Asia Pacific: Myopia Treatment Market Breakdown, by Type
11.1.1.13.2 Rest of Asia Pacific: Myopia Treatment Market Breakdown, by Treatment
11.1.1.13.3 Rest of Asia Pacific: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.13.4 Rest of Asia Pacific: Myopia Treatment Market Breakdown, by Age Group
11.1.1.13.5 Rest of Asia Pacific: Myopia Treatment Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Myopia Treatment Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Bausch Health Companies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Alcon AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CooperVision Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson Vision Care Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Nidek Co Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Haag-Streit AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Carl Zeiss AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The the Reporting Teams
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Myopia Treatment Market Segmentation
Table 2. Market Share (~) by Companies in the Global Myopia Treatment Market (%)
Table 3. Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 4. Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 5. Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 6. Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 7. Asia Pacific: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Country
Table 8. China: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 9. China: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 10. China: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 11. China: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 12. China: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 13. Japan: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 14. Japan: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 15. Japan: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 16. Japan: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 17. Japan: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 18. India: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 19. India: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 20. India: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 21. India: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 22. India: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 23. Australia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 24. Australia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 25. Australia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 26. Australia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 27. Australia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 28. South Korea: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 29. South Korea: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 30. South Korea: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 31. South Korea: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 32. South Korea: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 33. Rest of Asia Pacific: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 34. Rest of Asia Pacific: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 35. Rest of Asia Pacific: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 36. Rest of Asia Pacific: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 37. Rest of Asia Pacific: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 38. Recent Organic Growth Strategies in Myopia Treatment Market
Table 39. Recent Inorganic Growth Strategies in the Myopia Treatment Market
Table 40. Glossary of Terms, Myopia Treatment Market

LIST OF FIGURES

Figure 1. Asia Pacific Myopia Treatment Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Myopia Treatment Market Revenue (US$ Million), 2020-2030
Figure 5. Asia Pacific Myopia Treatment Market Share (%) – by Type (2022 and 2030)
Figure 6. High Myopia: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Degenerative Myopia: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Progressive Myopia: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Myopia Treatment Market Share (%) – by Treatment (2022 and 2030)
Figure 10. Low-Dose Atropine Eye Drops: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Refractive Surgery: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. LASIK: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. PRK: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Contact Lenses: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Ortho-K: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Asia Pacific Myopia Treatment Market Share (%) – by Age Group (2022 and 2030)
Figure 17. Adult Myopia: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Childhood Myopia: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Myopia Treatment Market Share (%) – by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Refractive Surgery Centers: Asia Pacific Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific: Myopia Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. China: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Japan: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. India: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Australia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. South Korea: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Rest of Asia Pacific: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Growth Strategies in Myopia Treatment Market

The List of Companies – Asia Pacific Myopia Treatment Market

1. Bausch Health Companies Inc
2. Alcon AG
3. CooperVision Inc
4. Johnson & Johnson Vision Care Inc
5. Nidek Co Ltd
6. Haag-Streit AG
7. Carl Zeiss AG

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific Myopia Treatment Market Forecast to 2030”